Live News EQUITY FLASH L impact Oct 26, 2026, 02:18 PM UTC ArriVent Presents Initial Phase 1 Data for ARR-217 ArriVent Biopharma presented initial Phase 1 data for ARR-217 in advanced solid tumors. AVBP SquawkNews Desk